10 completed, 3 terminated, 1 recruiting. 14 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 10, Terminated 3, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Pancreatitis, Chronic: new trials by email Literature Review of Pancreatitis, Chronic trials Research Report on Pancreatitis, Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis Dietary Supplement: Pancreatic enzyme preparation from microbial source that contains amylase (6650 DU), lipase (13000 FIP), and protease (7120 HUT, 15 SAPU, 3000 PC)., Standard of care porcine pancreatic enzyme preparation: amylase (8000 U), lipase (25000 U), and protease (1000 U) - Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency (EPI) | Phase 3 | Recruiting | Asian Institute of Gastroenterology, India | 134 | 2026-10-12 | 2026-10-26 |
| Simvastatin in the Prevention of Recurrent Pancreatitis Simvastatin 40mg, Placebo - Pancreatitis Relapsing | Phase 3 | Terminated | Enrique de-Madaria | 83 | 2017-09-29 | 2025-03-20 |
| Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy pancreaticojejunostomy - Pancreatic Neoplasms, Biliary Tract Neoplasms | Phase 3 | Completed | Fudan University | 308 | 2012-10-01 | 2014-12-04 |
| Prospective Study on Endoscopic Ultrasound (EUS) Celiac Bloc Efficacy in Chronic Pancreatitis EUS procedure with drug injection, EUS procedure - Pancreatitis, Chronic | Phase 3 | Terminated | Centre hospitalier de l'Université de Montréal (CHUM) | 2 | 2011-11-18 | 2020-05-13 |
| Pain and Chronic Pancreatitis - Clinical End Experimental Studies Pregabalin, placebo - Chronic Pancreatitis | Phase 2 / Phase 3 | Completed | Aalborg University Hospital | 64 | 2008-10-01 | 2010-08-20 |
| A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency SA-001 - Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy | Phase 3 | Completed | Abbott | 80 | 2008-07-01 | 2011-08-01 |
| Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis Triamcinolone, Bupivicaine alone - Chronic Pancreatitis | Phase 3 | Completed | The Cleveland Clinic | 40 | 2008-03-01 | 2017-06-14 |
| A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) Placebo, EUR-1008 (APT-1008) High Dose, EUR-1008 (APT-1008) Low Dose - Chronic Pancreatitis, Exocrine Pancreatic Insufficiency | Phase 3 | Completed | Forest Laboratories | 82 | 2008-01-01 | 2014-03-12 |
| Phase III ALTU-135 CP Safety Trial Liprotamase - Exocrine Pancreatic Insufficiency | Phase 3 | Terminated | Anthera Pharmaceuticals | 39 | 2007-12-01 | 2014-10-24 |
| Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Viokase® 16, Placebo, Proton pump inhibitor (PPI) - Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Phase 3 | Completed | Forest Laboratories | 50 | 2007-11-01 | 2017-03-16 |
| A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Pancrelipase delayed release capsule, Placebo Comparator - Chronic Pancreatitis, Pancreatectomy | Phase 3 | Completed | Solvay Pharmaceuticals | 52 | 2007-10-01 | 2011-08-10 |
| A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency SA-001, Placebo - Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Phase 3 | Completed | Abbott | 274 | 2007-05-01 | 2011-07-28 |
| Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain OraVescent Fentanyl - Pain | Phase 3 | Completed | Cephalon | 120 | 2006-08-01 | 2014-05-09 |
| Role of Antioxidants Supplementation in Chronic Pancreatitis Antioxidants, Placebo - Chronic Pancreatitis | Phase 3 | Completed | All India Institute of Medical Sciences | 127 | 2003-10-01 | 2009-01-29 |
Exocrine Pancreatic Insufficiency (7) · Pain (2) · Abdominal Pain (1) · Back Pain (1) · Biliary Tract Neoplasms (1) · Complex Regional Pain Syndromes (1) · Duodenal Neoplasms (1) · Fibromyalgia (1) · Neck Pain (1) · Neuralgia (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Pancreatic Neoplasms (1) · Pancreatitis (1)
Chronic Disease (14) · Digestive System Diseases (14) · Disease Attributes (14) · Pancreatic Diseases (14) · Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Pancreatitis (13) · Neurologic Manifestations (3) · Signs and Symptoms (3) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2) · Arthritis (1) · Autonomic Nervous System Diseases (1) · Biliary Tract Diseases (1)
Antioxidants (1) · Bupivacaine (1) · Lactose (1) · Lipase (1) · Omeprazole (1) · Pancreaticojejunostomy (1) · Pancrelipase (1) · Peptide Hydrolases (1) · Pharmaceutical Preparations (1) · Pregabalin (1) · Proton Pump Inhibitors (1) · Simvastatin (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · liprotamase lipase (1)
Abbott (2) · Forest Laboratories (2) · Aalborg University Hospital (1) · All India Institute of Medical Sciences (1) · Anthera Pharmaceuticals (1) · Asian Institute of Gastroenterology, India (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Cephalon (1) · Enrique de-Madaria (1) · Fudan University (1) · Solvay Pharmaceuticals (1) · The Cleveland Clinic (1)
United States (6) · Canada (2) · India (2) · Japan (2) · Poland (2) · Ukraine (2) · Belgium (1) · Bulgaria (1) · China (1) · Denmark (1) · Italy (1) · Netherlands (1) · Puerto Rico (1) · Russia (1) · Serbia (1)
Toshiaki Yamaguchi, BS Pharm (2) · Anand V Sahai, MD (1) · Payal Bhardwaj, MSc (1) · Pramod K Garg, MD, DM (1) · Rupjyoti Talukdar, MD (1) · Xian-Jun Yu, M.D. (1)
PMID 21848870, PMID 22879908, PMID 26036878, PMID 33644082, PMID 41482454
2004 (1)